Indian consumer healthcare business to be part of global deal, says Merck

By: |
New Delhi | September 05, 2017 7:43 PM

Merck Ltd today said its consumer health business in India will also be involved in plans by its parent Merck KGaA to sell or enter into partnerships regarding the consumer health business globally.

Merck, Indian consumer, healthcare, healthcare business, global deal, part of global deal, consumer health businessMerck Ltd today said its consumer health business in India will also be involved in plans by its parent Merck KGaA to sell or enter into partnerships regarding the consumer health business globally. (Image: Reuters)

Merck Ltd today said its consumer health business in India will also be involved in plans by its parent Merck KGaA to sell or enter into partnerships regarding the consumer health business globally. The ultimate holding company of the firm, Merck KGaA, has announced that it is preparing for strategic options for its consumer health business globally, including full or partial sales of the business as well as strategic partnerships, Merck Ltd said in a BSE filing. “This strategic initiative would involve the company’s consumer health business in India as well,” it added. In India, under its consumer health business, the company sells a broad range of OTC (over-the-counter) products for the treatment of minor ailments. These include muscle, joint and back pain relief products and remedies for cold and headache besides pro-biotic food supplements, vitamin C and products with vitamins, minerals and nutrients, specially for women and children.

“The implementation of measure and their specific design are subject to further analysis and decision making by competent bodies” the filing added. Commenting on the global development, Member of the Executive Board of Merck and CEO Healthcare Belén Garijo said: “We expect increasing internal constraints to fund the business to reach the required scale. Fully anticipating this, we are preparing strategic options.” Merck KGaA has well-recognised brands and products such as Bion, Femibion, Nasivin, Neurobion and Seven Seas in its Consumer Health product portfolio. Shares of Merck Ltd today closed 0.25 per cent lower at Rs 1,206.60 per scrip on BSE.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1B2B marketplace Flipkart Wholesale sees 3x jump in e-commerce adoption among kiranas in H1 2021
2ADQ in talks to infuse $400-500mn in Flipkart: sources
3WhatsApp is apparently sticking to using green colour for notifications in Android app